Tapewire

Nasdaq · USD

NKTR

NEKTAR THERAPEUTICS

Export transactions ↓
Tapewire entity
4364
SEC CIK
0000906709
Parsed reports
471

Last 12 months

Inside the activity.

0 purchase rows · 16 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202503
Dec 202500
Jan 202601
Feb 202602
Mar 202600
Apr 202600
May 202602
Jun 202606
Jul 202600
Aug 202602
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 04, 2025 Filed Sep 9, 2025 00:32 UTC
Zalevsky JonathanChief R&D Officer
SaleCommon Stock 307 $35.69 $10,956.83
Disclosure

SEC source: 0000950170-25-113692 · ownership.xml · nonDerivative · entry 4

Zalevsky Jonathan · CIK 0001789857 · Chief R&D Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,462

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F5 · price: This transaction was executed in multiple trades at prices ranging from $35.48 to $36.26. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

Read SEC document
September 04, 2025 Filed Sep 9, 2025 00:32 UTC
Zalevsky JonathanChief R&D Officer
SaleCommon Stock 189 $34.41 $6,503.49
Disclosure

SEC source: 0000950170-25-113692 · ownership.xml · nonDerivative · entry 3

Zalevsky Jonathan · CIK 0001789857 · Chief R&D Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,769

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F4 · price: This transaction was executed in multiple trades at prices ranging from $34.09 to $34.95. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

Read SEC document
September 04, 2025 Filed Sep 9, 2025 00:32 UTC
Zalevsky JonathanChief R&D Officer
SaleCommon Stock 432 $33.60 $14,515.20
Disclosure

SEC source: 0000950170-25-113692 · ownership.xml · nonDerivative · entry 2

Zalevsky Jonathan · CIK 0001789857 · Chief R&D Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,958

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F3 · price: This transaction was executed in multiple trades at prices ranging from $33.08 to $34.07. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

Read SEC document
September 04, 2025 Filed Sep 9, 2025 00:32 UTC
Zalevsky JonathanChief R&D Officer
SaleCommon Stock 793 $32.43 $25,716.99
Disclosure

SEC source: 0000950170-25-113692 · ownership.xml · nonDerivative · entry 1

Zalevsky Jonathan · CIK 0001789857 · Chief R&D Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,390

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $32.08 to $33.02 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

Read SEC document
September 04, 2025 Filed Sep 9, 2025 00:31 UTC
ROBIN HOWARD WDirector · President & CEO
SaleCommon Stock 1,134 $35.80 $40,597.20
Disclosure

SEC source: 0000950170-25-113691 · ownership.xml · nonDerivative · entry 4

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 62,674

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F5 · price: This transaction was executed in multiple trades at prices ranging from $35.35 to $36.11. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

Read SEC document
September 04, 2025 Filed Sep 9, 2025 00:31 UTC
ROBIN HOWARD WDirector · President & CEO
SaleCommon Stock 613 $34.40 $21,087.20
Disclosure

SEC source: 0000950170-25-113691 · ownership.xml · nonDerivative · entry 3

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 63,808

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F4 · price: This transaction was executed in multiple trades at prices ranging from $34.05 to $34.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

Read SEC document
September 04, 2025 Filed Sep 9, 2025 00:31 UTC
ROBIN HOWARD WDirector · President & CEO
SaleCommon Stock 1,496 $33.54 $50,175.84
Disclosure

SEC source: 0000950170-25-113691 · ownership.xml · nonDerivative · entry 2

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 64,421

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F3 · price: This transaction was executed in multiple trades at prices ranging from $33.02 to $33.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

Read SEC document
September 04, 2025 Filed Sep 9, 2025 00:31 UTC
ROBIN HOWARD WDirector · President & CEO
SaleCommon Stock 1,923 $32.37 $62,247.51
Disclosure

SEC source: 0000950170-25-113691 · ownership.xml · nonDerivative · entry 1

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 65,917

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $32.01 to $32.99 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

Read SEC document
September 02, 2025 Filed Sep 5, 2025 01:02 UTC
Zalevsky JonathanChief R&D Officer
SaleCommon Stock 485 $30.10 $14,598.50
Disclosure

SEC source: 0000950170-25-113130 · ownership.xml · nonDerivative · entry 1

Zalevsky Jonathan · CIK 0001789857 · Chief R&D Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 19,183

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $30.00 to $30.28 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

Read SEC document
September 02, 2025 Filed Sep 5, 2025 01:01 UTC
ROBIN HOWARD WDirector · President & CEO
SaleCommon Stock 1,500 $30.16 $45,240.00
Disclosure

SEC source: 0000950170-25-113129 · ownership.xml · nonDerivative · entry 1

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 67,840

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $30.00 to $30.30 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

Read SEC document
August 19, 2025 Filed Aug 22, 2025 01:05 UTC
Zalevsky JonathanChief R&D Officer
GrantStock Option · Derivative 16,666 $0.00 Strike: $0.50 $0.00
Disclosure

SEC source: 0000950170-25-110775 · ownership.xml · derivative · entry 2

Zalevsky Jonathan · CIK 0001789857 · Chief R&D Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,666

Underlying: Common Stock · 16,666 shares

Expires 2031-12-12

F4 · security: These stock options were granted on December 13, 2023 under the 2017 Plan and at the time of their grant were subject to both performance-based and time-based vesting requirements. The time-based vesting is on a monthly pro-rata basis over a period of three years from the date of grant.

F5 · derivative.exercise_date: The Organization and Compensation Committee of the Board of Directors of the Issuer determined on July 17, 2025 that the performance-based vesting requirement for these stock options was satisfied and these stock options vested on August 19, 2025 (subject to remaining time-based vesting requirements).

Read SEC document
August 19, 2025 Filed Aug 22, 2025 01:05 UTC
Zalevsky JonathanChief R&D Officer
SaleCommon Stock 725 $26.59 $19,277.75
Disclosure

SEC source: 0000950170-25-110775 · ownership.xml · nonDerivative · entry 1

Zalevsky Jonathan · CIK 0001789857 · Chief R&D Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,668

F1 · shares: Represents the number of shares sold by the reporting person to cover required tax withholding obligations in connection with the vesting of the RSUs held by the reporting person and does not represent a discretionary trade by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $26.19 to $27.15 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

F3 · balance_after: On June 8, 2025, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the "Reverse Stock Split"). All amounts of securities listed herein have been adjusted to reflect the effect of the Reverse Stock Split.

Read SEC document
August 19, 2025 Filed Aug 22, 2025 01:04 UTC
Wilson Mark AndrewChief Legal Officer
GrantStock Option · Derivative 21,666 $0.00 Strike: $0.50 $0.00
Disclosure

SEC source: 0000950170-25-110774 · ownership.xml · derivative · entry 2

Wilson Mark Andrew · CIK 0001808356 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,666

Underlying: Common Stock · 21,666 shares

Expires 2031-12-12

F5 · security: These stock options were granted on December 13, 2023 under the 2017 Plan and at the time of their grant were subject to both performance-based and time-based vesting requirements. The time-based vesting is on a monthly pro-rata basis over a period of three years from the date of grant.

F6 · derivative.exercise_date: The Organization and Compensation Committee of the Board of Directors of the Issuer determined on July 17, 2025 that the performance-based vesting requirement for these stock options was satisfied and these stock options vested on August 19, 2025 (subject to remaining time-based vesting requirements).

Read SEC document
August 19, 2025 Filed Aug 22, 2025 01:04 UTC
Wilson Mark AndrewChief Legal Officer
SaleCommon Stock 676 $26.59 $17,974.84
Disclosure

SEC source: 0000950170-25-110774 · ownership.xml · nonDerivative · entry 1

Wilson Mark Andrew · CIK 0001808356 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,312

F1 · shares: Represents the number of shares sold by the reporting person to cover required tax withholding obligations in connection with the vesting of the RSUs held by the reporting person and does not represent a discretionary trade by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $26.19 to $27.15 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

F3 · balance_after: This number includes 508 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under the plan is exempt under Rule 16b-3(c).

F4 · balance_after: On June 8, 2025, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the "Reverse Stock Split"). All amounts of securities listed herein have been adjusted to reflect the effect of the Reverse Stock Split.

Read SEC document
August 19, 2025 Filed Aug 22, 2025 01:03 UTC
ROBIN HOWARD WDirector · President & CEO
GrantStock Option · Derivative 86,666 $0.00 Strike: $0.50 $0.00
Disclosure

SEC source: 0000950170-25-110773 · ownership.xml · derivative · entry 3

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,666

Underlying: Common Stock · 86,666 shares

Expires 2031-12-12

F4 · security: These stock options were granted on December 13, 2023 under the 2017 Plan and at the time of their grant were subject to both performance-based and time-based vesting requirements. The time-based vesting is on a monthly pro-rata basis over a period of three years from the date of grant.

F5 · derivative.exercise_date: The Organization and Compensation Committee of the Board of Directors of the Issuer determined on July 17, 2025 that the performance-based vesting requirement for these stock options was satisfied and these stock options vested on August 19, 2025 (subject to remaining time-based vesting requirements).

Read SEC document
August 19, 2025 Filed Aug 22, 2025 01:03 UTC
ROBIN HOWARD WDirector · President & CEO
SaleCommon Stock 1,573 $26.59 $41,826.07
Disclosure

SEC source: 0000950170-25-110773 · ownership.xml · nonDerivative · entry 1

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,340

F1 · shares: Represents the number of shares sold by the reporting person to cover required tax withholding obligations in connection with the vesting of the RSUs held by the reporting person and does not represent a discretionary trade by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $26.19 to $27.15 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

F3 · balance_after: On June 8, 2025, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the "Reverse Stock Split"). All amounts of securities listed herein have been adjusted to reflect the effect of the Reverse Stock Split.

Read SEC document
May 19, 2025 Filed May 22, 2025 00:08 UTC
Zalevsky JonathanChief R&D Officer
SaleCommon Stock 10,712 $0.67 $7,177.04
Disclosure

SEC source: 0000950170-25-075979 · ownership.xml · nonDerivative · entry 1

Zalevsky Jonathan · CIK 0001789857 · Chief R&D Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 305,892

F1 · shares: Represents the number of shares sold by the reporting person to cover required tax withholding obligations in connection with the vesting of the RSUs held by the reporting person and does not represent a discretionary trade by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $0.66 to $0.69. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

Read SEC document
May 19, 2025 Filed May 22, 2025 00:07 UTC
Wilson Mark AndrewChief Legal Officer
SaleCommon Stock 9,996 $0.67 $6,697.32
Disclosure

SEC source: 0000950170-25-075977 · ownership.xml · nonDerivative · entry 1

Wilson Mark Andrew · CIK 0001808356 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 314,296

F1 · shares: Represents the number of shares sold by the reporting person to cover required tax withholding obligations in connection with the vesting of the RSUs held by the reporting person and does not represent a discretionary trade by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $0.66 to $0.69 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

F3 · balance_after: This number includes 7,107 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under the plan is exempt under Rule 16b-3(c).

Read SEC document
May 19, 2025 Filed May 22, 2025 00:07 UTC
ROBIN HOWARD WDirector · President & CEO
SaleCommon Stock 23,208 $0.67 $15,549.36
Disclosure

SEC source: 0000950170-25-075976 · ownership.xml · nonDerivative · entry 1

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,063,693

F1 · shares: Represents the number of shares sold by the reporting person to cover required tax withholding obligations in connection with the vesting of the RSUs held by the reporting person and does not represent a discretionary trade by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $0.66 to $0.69. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

Read SEC document
February 19, 2025 Filed Feb 21, 2025 23:07 UTC
Zalevsky JonathanChief R&D Officer
SaleCommon Stock 10,300 $1.01 $10,403.00
Disclosure

SEC source: 0000950170-25-025043 · ownership.xml · nonDerivative · entry 1

Zalevsky Jonathan · CIK 0001789857 · Chief R&D Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 316,604

F1 · shares: Represents the number of shares sold by the reporting person to cover required tax withholding obligations in connection with the vesting of the RSUs held by the reporting person and does not represent a discretionary trade by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $1.00 to $1.04. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

Read SEC document
February 19, 2025 Filed Feb 21, 2025 23:04 UTC
ROBIN HOWARD WDirector · President & CEO
SaleCommon Stock 23,774 $1.01 $24,011.74
Disclosure

SEC source: 0000950170-25-025035 · ownership.xml · nonDerivative · entry 1

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,086,901

F1 · shares: Represents the number of shares sold by the reporting person to cover required tax withholding obligations in connection with the vesting of the RSUs held by the reporting person and does not represent a discretionary trade by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $1.00 to $1.04. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

Read SEC document
February 19, 2025 Filed Feb 21, 2025 23:06 UTC
Wilson Mark AndrewChief Legal Officer
SaleCommon Stock 11,040 $1.01 $11,150.40
Disclosure

SEC source: 0000950170-25-025040 · ownership.xml · nonDerivative · entry 1

Wilson Mark Andrew · CIK 0001808356 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 324,292

F1 · shares: Represents the number of shares sold by the reporting person to cover required tax withholding obligations in connection with the vesting of the RSUs held by the reporting person and does not represent a discretionary trade by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $1.00 to $1.04 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

F3 · balance_after: This number includes 7,107 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under the plan is exempt under Rule 16b-3(c).

Read SEC document
December 24, 2024 Filed Dec 27, 2024 00:04 UTC
Wilson Mark AndrewChief Legal Officer
SaleCommon Stock 16,560 $0.89 $14,738.40
Disclosure

SEC source: 0000950170-24-140591 · ownership.xml · nonDerivative · entry 2

Wilson Mark Andrew · CIK 0001808356 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 335,332

F1 · shares: Represents the number of shares sold by the reporting person to cover required tax withholding obligations in connection with the vesting of the RSUs held by the reporting person and does not represent a discretionary trade by the reporting person.

F4 · price: This transaction was executed in multiple trades at prices ranging from $.89 to $.90 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

F3 · balance_after: This number includes 7,107 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under the plan is exempt under Rule 16b-3(c).

Read SEC document
December 23, 2024 Filed Dec 27, 2024 00:04 UTC
Wilson Mark AndrewChief Legal Officer
SaleCommon Stock 33,402 $0.90 $30,061.80
Disclosure

SEC source: 0000950170-24-140591 · ownership.xml · nonDerivative · entry 1

Wilson Mark Andrew · CIK 0001808356 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 351,892

F1 · shares: Represents the number of shares sold by the reporting person to cover required tax withholding obligations in connection with the vesting of the RSUs held by the reporting person and does not represent a discretionary trade by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $.87 to $.91 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

F3 · balance_after: This number includes 7,107 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under the plan is exempt under Rule 16b-3(c).

Read SEC document
December 19, 2024 Filed Dec 21, 2024 01:33 UTC
Zalevsky JonathanChief R&D Officer
SaleCommon Stock 51,115 $0.94 $48,048.10
Disclosure

SEC source: 0000950170-24-139242 · ownership.xml · nonDerivative · entry 1

Zalevsky Jonathan · CIK 0001789857 · Chief R&D Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 326,904

F1 · shares: Represents the number of shares sold by the reporting person to cover required tax withholding obligations in connection with the vesting of the RSUs held by the reporting person and does not represent a discretionary trade by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $.89 to $1.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

Read SEC document
December 18, 2024 Filed Dec 20, 2024 02:08 UTC
ROBIN HOWARD WDirector · President & CEO
SaleCommon Stock 85,035 $0.99 $84,184.65
Disclosure

SEC source: 0000950170-24-138693 · ownership.xml · nonDerivative · entry 2

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,110,675

F1 · shares: Represents the number of shares sold by the reporting person to cover required tax withholding obligations in connection with the vesting of the RSUs held by the reporting person and does not represent a discretionary trade by the reporting person.

F3 · price: This transaction was executed in multiple trades at prices ranging from $.93 to $1.04. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

Read SEC document
December 17, 2024 Filed Dec 20, 2024 02:08 UTC
ROBIN HOWARD WDirector · President & CEO
SaleCommon Stock 46,995 $1.01 $47,464.95
Disclosure

SEC source: 0000950170-24-138693 · ownership.xml · nonDerivative · entry 1

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,195,710

F1 · shares: Represents the number of shares sold by the reporting person to cover required tax withholding obligations in connection with the vesting of the RSUs held by the reporting person and does not represent a discretionary trade by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $1.00 to $1.03. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

Read SEC document
December 13, 2024 Filed Dec 18, 2024 01:55 UTC
Zalevsky JonathanChief R&D Officer
GrantStock Option · Derivative 375,000 $0.00 Strike: $1.01 $0.00
Disclosure

SEC source: 0000950170-24-137545 · ownership.xml · derivative · entry 3

Zalevsky Jonathan · CIK 0001789857 · Chief R&D Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 375,000

Underlying: Common Stock · 375,000 shares

Expires 2032-12-12

F5 · derivative.exercise_date: Stock options vest over four years from the date of grant, (December 13, 2024) in equal monthly installments based on continued service.

Read SEC document
December 13, 2024 Filed Dec 18, 2024 01:55 UTC
Zalevsky JonathanChief R&D Officer
GrantStock Option · Derivative 270,000 $0.00 Strike: $4.91 $0.00
Disclosure

SEC source: 0000950170-24-137545 · ownership.xml · derivative · entry 2

Zalevsky Jonathan · CIK 0001789857 · Chief R&D Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 270,000

Underlying: Common Stock · 270,000 shares

Expires 2030-08-14

F3 · security: These stock options were granted on August 15, 2022 under the 2017 Plan and at the time of their grant were subject to both performance-based and time-based vesting requirements. The time-based vesting is on a monthly pro-rata basis over a period of three years from the date of grant.

F4 · derivative.exercise_date: The Compensation Committee determined on November 18, 2024 that the performance-based vesting requirement for these stock options was satisfied and these stock options vested on December 13, 2024 (subject to remaining time-based vesting requirements).

Read SEC document
December 13, 2024 Filed Dec 18, 2024 01:55 UTC
Zalevsky JonathanChief R&D Officer
GrantCommon Stock 135,000 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-137545 · ownership.xml · nonDerivative · entry 1

Zalevsky Jonathan · CIK 0001789857 · Chief R&D Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 378,019

F1 · security: Common stock was acquired pursuant to a grant of restricted stock units ("RSU"). Each RSU awarded represents a contingent right to receive, upon vesting of the unit, one share of Common Stock of the Issuer. These RSUs were granted on August 15, 2022 under the Issuer's Amended and Restated 2017 Performance Incentive Plan (the "2017 Plan") and at the time of their grant were subject to both performance-based and time-based vesting requirements. The time-based vesting is on a quarterly pro-rata basis over a period of three years from the date of grant.

F2 · date: The Organization and Compensation Committee of the Board of Directors of the Issuer ("Compensation Committee") determined on November 18, 2024 that the performance-based vesting requirement for these RSUs was satisfied and these RSUs vested on December 13, 2024 (subject to remaining time-based vesting requirements).

Read SEC document
December 13, 2024 Filed Dec 18, 2024 01:54 UTC
Wilson Mark AndrewChief Legal Officer
GrantStock Option · Derivative 325,000 $0.00 Strike: $1.01 $0.00
Disclosure

SEC source: 0000950170-24-137544 · ownership.xml · derivative · entry 3

Wilson Mark Andrew · CIK 0001808356 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 325,000

Underlying: Common Stock · 325,000 shares

Expires 2032-12-12

F6 · derivative.exercise_date: Stock options vest over four years from the date of grant, (December 13, 2024) in equal monthly installments based on continued service.

Read SEC document
December 13, 2024 Filed Dec 18, 2024 01:54 UTC
Wilson Mark AndrewChief Legal Officer
GrantStock Option · Derivative 331,875 $0.00 Strike: $4.91 $0.00
Disclosure

SEC source: 0000950170-24-137544 · ownership.xml · derivative · entry 2

Wilson Mark Andrew · CIK 0001808356 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 331,875

Underlying: Common Stock · 331,875 shares

Expires 2030-08-14

F4 · security: These stock options were granted on August 15, 2022 under the 2017 Plan and at the time of their grant were subject to both performance-based and time-based vesting requirements. The time-based vesting is on a monthly pro-rata basis over a period of three years from the date of grant.

F5 · derivative.exercise_date: The Compensation Committee determined on November 18, 2024 that the performance-based vesting requirement for these stock options was satisfied and these stock options vested on December 13, 2024 (subject to remaining time-based vesting requirements).

Read SEC document
December 13, 2024 Filed Dec 18, 2024 01:54 UTC
Wilson Mark AndrewChief Legal Officer
GrantCommon Stock 165,938 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-137544 · ownership.xml · nonDerivative · entry 1

Wilson Mark Andrew · CIK 0001808356 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 385,294

F1 · security: Common stock was acquired pursuant to a grant of restricted stock units ("RSU"). Each RSU awarded represents a contingent right to receive, upon vesting of the unit, one share of Common Stock of the Issuer. These RSUs were granted on August 15, 2022 under the Issuer's Amended and Restated 2017 Performance Incentive Plan (the "2017 Plan") and at the time of their grant were subject to both performance-based and time-based vesting requirements. The time-based vesting is on a quarterly pro-rata basis over a period of three years from the date of grant.

F2 · date: The Organization and Compensation Committee of the Board of Directors of the Issuer ("Compensation Committee") determined on November 18, 2024 that the performance-based vesting requirement for these RSUs was satisfied and these RSUs vested on December 13, 2024 (subject to remaining time-based vesting requirements).

F3 · balance_after: This number includes 7,107 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under the plan is exempt under Rule 16b-3(c).

Read SEC document
December 13, 2024 Filed Dec 18, 2024 01:54 UTC
ROBIN HOWARD WDirector · President & CEO
GrantStock Option · Derivative 1,300,000 $0.00 Strike: $1.01 $0.00
Disclosure

SEC source: 0000950170-24-137543 · ownership.xml · derivative · entry 4

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,300,000

Underlying: Common Stock · 1,300,000 shares

Expires 2032-12-12

F5 · derivative.exercise_date: Stock options vest over four years from the date of grant, (December 13, 2024) in equal monthly installments based on continued service.

Read SEC document
December 13, 2024 Filed Dec 18, 2024 01:54 UTC
ROBIN HOWARD WDirector · President & CEO
GrantStock Option · Derivative 821,250 $0.00 Strike: $4.91 $0.00
Disclosure

SEC source: 0000950170-24-137543 · ownership.xml · derivative · entry 3

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 821,250

Underlying: Common Stock · 821,250 shares

Expires 2030-08-14

F3 · security: These stock options were granted on August 15, 2022 under the 2017 Plan and at the time of their grant were subject to both performance-based and time-based vesting requirements. The time-based vesting is on a monthly pro-rata basis over a period of three years from the date of grant.

F4 · derivative.exercise_date: The Compensation Committee determined on November 18, 2024 that the performance-based vesting requirement for these stock options was satisfied and these stock options vested on December 13, 2024 (subject to remaining time-based vesting requirements).

Read SEC document
December 13, 2024 Filed Dec 18, 2024 01:54 UTC
ROBIN HOWARD WDirector · President & CEO
GrantCommon Stock 410,625 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-137543 · ownership.xml · nonDerivative · entry 1

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,242,705

F1 · security: Common stock was acquired pursuant to a grant of restricted stock units ("RSU"). Each RSU awarded represents a contingent right to receive, upon vesting of the unit, one share of Common Stock of the Issuer. These RSUs were granted on August 15, 2022 under the Issuer's Amended and Restated 2017 Performance Incentive Plan (the "2017 Plan") and at the time of their grant were subject to both performance-based and time-based vesting requirements. The time-based vesting is on a quarterly pro-rata basis over a period of three years from the date of grant.

F2 · date: The Organization and Compensation Committee of the Board of Directors of the Issuer ("Compensation Committee") determined on November 18, 2024 that the performance-based vesting requirement for these RSUs was satisfied and these RSUs vested on December 13, 2024 (subject to remaining time-based vesting requirements).

Read SEC document
November 19, 2024 Filed Nov 21, 2024 01:37 UTC
Zalevsky JonathanChief R&D Officer
SaleCommon Stock 7,785 $1.01 $7,862.85
Disclosure

SEC source: 0000950170-24-129463 · ownership.xml · nonDerivative · entry 1

Zalevsky Jonathan · CIK 0001789857 · Chief R&D Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 243,019

F1 · shares: Represents the number of shares sold by the reporting person to cover required tax withholding obligations in connection with the vesting of the RSUs held by the reporting person and does not represent a discretionary trade by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $1.00 to $1.04. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

Read SEC document
November 19, 2024 Filed Nov 21, 2024 01:36 UTC
Wilson Mark AndrewChief Legal Officer
SaleCommon Stock 6,407 $1.01 $6,471.07
Disclosure

SEC source: 0000950170-24-129462 · ownership.xml · nonDerivative · entry 1

Wilson Mark Andrew · CIK 0001808356 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 218,856

F1 · shares: Represents the number of shares sold by the reporting person to cover required tax withholding obligations in connection with the vesting of the RSUs held by the reporting person and does not represent a discretionary trade by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $1.00 to $1.04. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

F3 · balance_after: This number includes 6,607 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under the plan is exempt under Rule 16b-3(c).

Read SEC document
November 19, 2024 Filed Nov 21, 2024 01:36 UTC
ROBIN HOWARD WDirector · President & CEO
SaleCommon Stock 16,278 $1.01 $16,440.78
Disclosure

SEC source: 0000950170-24-129461 · ownership.xml · nonDerivative · entry 1

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 832,080

F1 · shares: Represents the number of shares sold by the reporting person to cover required tax withholding obligations in connection with the vesting of the RSUs held by the reporting person and does not represent a discretionary trade by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $1.00 to $1.04. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

Read SEC document
September 18, 2024 Filed Jan 18, 2025 01:39 UTC GrantStock Option · Derivative 120,000 $0.00 Strike: $1.26 $0.00
Disclosure

SEC source: 0000950170-25-006894 · ownership.xml · derivative · entry 1

WHITFIELD ROY A · CIK 0000936728 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,000

Underlying: Common Stock · 120,000 shares

Expires 2032-09-17

F1 · derivative.exercise_date: This stock option vests in equal monthly installments over the one-year period beginning on September 18, 2024.

Read SEC document
September 18, 2024 Filed Jan 18, 2025 01:37 UTC GrantStock Option · Derivative 120,000 $0.00 Strike: $1.26 $0.00
Disclosure

SEC source: 0000950170-25-006891 · ownership.xml · derivative · entry 1

GREER R SCOTT · CIK 0001211703 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,000

Underlying: Common Stock · 120,000 shares

Expires 2032-09-17

F1 · derivative.exercise_date: This stock option vests in equal monthly installments over the one-year period beginning on September 18, 2024.

Read SEC document
September 18, 2024 Filed Jan 18, 2025 01:35 UTC
CHESS ROBERTDirector
GrantStock Option · Derivative 120,000 $0.00 Strike: $1.26 $0.00
Disclosure

SEC source: 0000950170-25-006887 · ownership.xml · derivative · entry 1

CHESS ROBERT · CIK 0001227886 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,000

Underlying: Common Stock · 120,000 shares

Expires 2032-09-17

F1 · derivative.exercise_date: This stock option vests in equal monthly installments over the one-year period beginning on September 18, 2024.

Read SEC document
September 18, 2024 Filed Jan 18, 2025 01:32 UTC GrantStock Option · Derivative 120,000 $0.00 Strike: $1.26 $0.00
Disclosure

SEC source: 0000950170-25-006883 · ownership.xml · derivative · entry 1

Brainard Diana · CIK 0001818070 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,000

Underlying: Common Stock · 120,000 shares

Expires 2032-09-17

F1 · derivative.exercise_date: This stock option vests in equal monthly installments over the one-year period beginning on September 18, 2024.

Read SEC document
September 18, 2024 Filed Jan 18, 2025 01:30 UTC GrantStock Option · Derivative 120,000 $0.00 Strike: $1.26 $0.00
Disclosure

SEC source: 0000950170-25-006880 · ownership.xml · derivative · entry 1

Ajer Jeffrey Robert · CIK 0001557533 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,000

Underlying: Common Stock · 120,000 shares

Expires 2032-09-17

F1 · derivative.exercise_date: This stock option vests in equal monthly installments over the one-year period beginning on September 18, 2024.

Read SEC document
August 19, 2024 Filed Aug 21, 2024 01:15 UTC
Zalevsky JonathanChief R&D Officer
SaleCommon Stock 6,866 $1.28 $8,788.48
Disclosure

SEC source: 0000950170-24-099354 · ownership.xml · nonDerivative · entry 1

Zalevsky Jonathan · CIK 0001789857 · Chief R&D Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250,804

F1 · shares: Represents the number of shares sold by the reporting person to cover required tax withholding obligations in connection with the vesting of the RSUs held by the reporting person and does not represent a discretionary trade by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $1.24 to $1.32. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

Read SEC document
August 19, 2024 Filed Aug 21, 2024 01:15 UTC
Wilson Mark AndrewChief Legal Officer
SaleCommon Stock 5,651 $1.28 $7,233.28
Disclosure

SEC source: 0000950170-24-099353 · ownership.xml · nonDerivative · entry 1

Wilson Mark Andrew · CIK 0001808356 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 225,263

F1 · shares: Represents the number of shares sold by the reporting person to cover required tax withholding obligations in connection with the vesting of the RSUs held by the reporting person and does not represent a discretionary trade by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $1.24 to $1.32. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

F3 · balance_after: This number includes 6,607 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under the plan is exempt under Rule 16b-3(c).

Read SEC document
August 19, 2024 Filed Aug 21, 2024 01:14 UTC
ROBIN HOWARD WDirector · President & CEO
SaleCommon Stock 14,881 $1.28 $19,047.68
Disclosure

SEC source: 0000950170-24-099352 · ownership.xml · nonDerivative · entry 1

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 848,358

F1 · shares: Represents the number of shares sold by the reporting person to cover required tax withholding obligations in connection with the vesting of the RSUs held by the reporting person and does not represent a discretionary trade by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $1.24 to $1.32. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

Read SEC document
June 14, 2024 Filed Jun 14, 2024 22:02 UTC
CHESS ROBERTDirector
SaleCommon Stock 19,500 $1.20 $23,400.00
Disclosure

SEC source: 0000950170-24-073851 · ownership.xml · nonDerivative · entry 1

CHESS ROBERT · CIK 0001227886 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 255,273

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $1.19 to $1.23. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

Read SEC document
May 17, 2024 Filed May 21, 2024 01:14 UTC
ROBIN HOWARD WDirector · President & CEO
SaleCommon Stock 16,650 $1.75 $29,137.50
Disclosure

SEC source: 0000950170-24-062646 · ownership.xml · nonDerivative · entry 1

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 863,239

F1 · shares: Represents the number of shares sold by the reporting person to cover required tax withholding obligations in connection with the vesting of the RSUs held by the reporting person and does not represent a discretionary trade by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $1.72 to $1.80. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

Read SEC document
May 17, 2024 Filed May 21, 2024 01:13 UTC
Zalevsky JonathanChief R&D Officer
SaleCommon Stock 7,355 $1.75 $12,871.25
Disclosure

SEC source: 0000950170-24-062645 · ownership.xml · nonDerivative · entry 1

Zalevsky Jonathan · CIK 0001789857 · Chief R&D Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 257,670

F1 · shares: Represents the number of shares sold by the reporting person to cover required tax withholding obligations in connection with the vesting of the RSUs held by the reporting person and does not represent a discretionary trade by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $1.72 to $1.80. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.